Results 251 to 260 of about 38,595 (290)
The possible effect of anti-diabetic agents GLP-1RA and SGLT-2i on the respiratory system function
EndocrineType 2 Diabetes (T2D) is a chronic disease with increasing incidence and prevalence and serious chronic complications, especially from cardiovascular system. However, other organs can be affected too.
Paraskevi Katsaounou +2 more
exaly +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Semaglutide 2.4 Mg: The Latest GLP-1RA Approved for Obesity
Journal of Investigative Medicine, 2022Ricardo Villela, Ricardo Correa
openaire +2 more sources
Can GLP-1RAs redefine transplantation standard of care?
Trends in Pharmacological SciencesMetabolic derangements, particularly obesity and post-transplant diabetes mellitus, remain major challenges in solid organ transplantation, contributing to graft dysfunction and increased morbidity. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as promising agents due to their glucose-lowering, weight-reducing, and cardiorenal ...
openaire +2 more sources
The benefit of GLP-1RA in different age groups in the cardiovascular outcome trials
Diabetes Research and Clinical Practice, 2021Basem M Mishriky +2 more
exaly
Kniearthrose: Lange GLP-1RA-Therapie ist krankheitsmodifizierend
Aktuelle RheumatologieEine Gewichtsreduktion gilt als eine der ersten Maßnahmen bei Kniearthrose (KOA). Jüngste Erkenntnisse deuten darauf hin, dass bei Diabetes mellitus Typ 2 empfohlene Glucagonlike-Peptid-1-Rezeptor-Agonisten (GLP-1RAs), die eine Gewichtsreduktion bewirken, eine geringe Verbesserung ...
openaire +1 more source
IP06-36 CHARACTERIZING KIDNEY STONE EPISODES BY GLP-1RA MEDICATION IN GLP-1RA USERS
Journal of UrologyShreya Thiagarajan +3 more
openaire +1 more source